检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:易智彪[1] 纪云西[1] 蒋历[2] 宋春晖[2] 吴大力[3] 陈大舜[2]
机构地区:[1]广州中医药大学新药研究开发中心,广东广州510006 [2]湖南中医药大学,湖南长沙410007 [3]广西中医学院,广西南宁530001
出 处:《亚太传统医药》2010年第7期7-10,共4页Asia-Pacific Traditional Medicine
摘 要:目的:观察降糖明目汤对背景期糖尿病视网膜病变(BDR)模型兔的sICAM-1、NF-κB的影响。方法:BDR模型兔随机分为模型组、降糖明目汤治疗组和西药导升明对照组,检测血清sICAM-1、视网膜NF-κBp65表达,并与正常组比较。结果:模型组实验兔血清sICAM-1浓度明显高于中药治疗组、西药对照组和正常组(P<0.01);西药对照组与中药治疗组、正常组比较有极显著性差异(P<0.01);但中药治疗组与正常组比较无显著性差异(P>0.05)。模型组实验兔视网膜出现少量新生血管,且视网膜NF-κBp65强表达,与正常组、中药治疗组比较,有极显著差异(P<0.01),与西药对照组比较无显著性差异(P>0.05);中药治疗组与西药对照组比较有显著性差异(P<0.05)。中药治疗组与正常组比较无显著性差异(P>0.05)。结论:中药降糖明目汤具有一定的抑制NF-κBp65的表达,降低血清sICAM-1浓度的作用。Objective(To) observe the effect of jiangtangmingmu formula to BDR model Rabbits' sICAM-1 and NF-κB p65. Methods: BDR model Rabbils were randomly divided into jiangtang-mingmu tormula group, western medicine Doxium group and model group, detecting serum sICAM-I, the expression of NF-κB p65 in retina, and compared with normal group's. Results: The density of serum slCAM-1 of model gnmp obviously increases and there is obviously significance compared with the other three groups (P〈0.01), the same obviously significance among western medicine group and control group,normal group (P〈0.01), but there no significance between control group and normal group (P〉0.05). there is high expression of NF-κB p65 in retina of model group, and statistic significance compared with control group and normal group (P〈0.01), but no significance with western medicine group (P〉0.05). there is statistic significance between control group arid westeru medicine group (P〈0.05), and no significance with between control group and normal group (P〉0.05). Conclusion: Jiangtang-mingmu formula can inhibit expression of NF-κB p65 and lower down the density of serum sICAM-1.
关 键 词:降糖明目汤 背景期糖尿病视网膜病变 SICAM-1 NF-ΚB
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15